Goldman Sachs Group Inc Prothena Corp Public LTD CO Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Goldman Sachs Group Inc holds 528,323 shares of PRTA stock, worth $5.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
528,323
Previous 510,462
3.5%
Holding current value
$5.48 Million
Previous $6.32 Million
49.26%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding PRTA
# of Institutions
219Shares Held
34.4MCall Options Held
879KPut Options Held
791K-
Black Rock Inc. New York, NY3.86MShares$40 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.38MShares$35 Million3.14% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$23.2 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$22.6 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$13.2 Million1.75% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $487M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...